Gritstone bio, Inc.

OTCPK:GRTS.Q Rapporto sulle azioni

Cap. di mercato: US$3.2m

Gritstone bio Gestione

Gestione criteri di controllo 2/4

Gritstone bio Il CEO è Andrew Allen, nominato in Aug2015, e ha un mandato di 9.25 anni. la retribuzione annua totale è $ 3.44M, composta da 18.8% di stipendio e 81.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.53% delle azioni della società, per un valore di $ 48.55K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.7 anni e 6.5 anni.

Informazioni chiave

Andrew Allen

Amministratore delegato

US$3.4m

Compenso totale

Percentuale dello stipendio del CEO18.8%
Mandato del CEO9.3yrs
Proprietà del CEO1.5%
Durata media del management3.7yrs
Durata media del Consiglio di amministrazione6.5yrs

Aggiornamenti recenti sulla gestione

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Recent updates

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering

Apr 07

Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Aug 14
Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Gritstone bio: Early Data For SLATE Candidate Sets Up 2023 Catalyst

Sep 26

Gritstone reaches six-month high on publication of data for cancer vaccine

Aug 16

Gritstone bio announces $80M credit facility

Jul 21

Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Jul 07
Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Gritstone bio: Potential To Advance Colorectal Cancer Treatment

Jul 05

Gritstone bio: Investing In A Premium mRNA Technology At A Discounted Valuation

Jun 14

Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

Mar 17
Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Mar 05
We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Gritstone: Why The Stock Fell On Positive Data

Jan 18

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Andrew Allen rispetto agli utili di Gritstone bio?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$133m

Mar 31 2024n/an/a

-US$145m

Dec 31 2023US$3mUS$646k

-US$138m

Sep 30 2023n/an/a

-US$139m

Jun 30 2023n/an/a

-US$130m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$3mUS$620k

-US$120m

Sep 30 2022n/an/a

-US$118m

Jun 30 2022n/an/a

-US$116m

Mar 31 2022n/an/a

-US$112m

Dec 31 2021US$4mUS$589k

-US$75m

Sep 30 2021n/an/a

-US$72m

Jun 30 2021n/an/a

-US$70m

Mar 31 2021n/an/a

-US$71m

Dec 31 2020US$2mUS$569k

-US$105m

Sep 30 2020n/an/a

-US$106m

Jun 30 2020n/an/a

-US$107m

Mar 31 2020n/an/a

-US$103m

Dec 31 2019US$2mUS$533k

-US$94m

Sep 30 2019n/an/a

-US$84m

Jun 30 2019n/an/a

-US$75m

Mar 31 2019n/an/a

-US$69m

Dec 31 2018US$2mUS$475k

-US$65m

Sep 30 2018n/an/a

-US$65m

Jun 30 2018n/an/a

-US$56m

Mar 31 2018n/an/a

-US$47m

Dec 31 2017US$592kUS$436k

-US$41m

Compensazione vs Mercato: La retribuzione totale di Andrew ($USD 3.44M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 650.80K ).

Compensazione vs guadagni: La retribuzione di Andrew è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Andrew Allen (58 yo)

9.3yrs

Mandato

US$3,444,071

Compensazione

Dr. Andrew R. Allen, BM, BCh, MA, MRCP, M.D., Ph D., serves as Independent Director at Verge Analytics, Inc. since September 2021. He has also held clinical development leadership positions at Chiron Corpo...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Andrew Allen
Co-Founder9.3yrsUS$3.44m1.53%
$ 48.6k
Erin Jones
Executive VP & COO3.7yrsUS$1.52m0.063%
$ 2.0k
Karin Jooss
Executive VP and Head of Research & Development3.7yrsUS$1.58m0.39%
$ 12.4k
Vassiliki Economides
Executive VP & CFO3.4yrsNessun dato0.059%
$ 1.9k
James Cho
Chief Accounting Officer3.8yrsNessun dato0.070%
$ 2.2k
George MacDougall
Director of Investor Relations & Corporate Communicationsno dataNessun datoNessun dato
Stacy Proctor
Executive VP & Chief People Officer3.3yrsNessun datoNessun dato
Matthew Hawryluk
Executive VP & Chief Business Officer9yrsNessun dato0.034%
$ 1.1k

3.7yrs

Durata media

52yo

Età media

Gestione esperta: Il team dirigenziale di GRTS.Q è considerato esperto (durata media dell'incarico 3.7 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Andrew Allen
Co-Founder9.3yrsUS$3.44m1.53%
$ 48.6k
Elaine Jones
Independent Chairman of the Board5.2yrsUS$176.00k0%
$ 0
Stephen Webster
Independent Directorless than a yearNessun dato0.021%
$ 670.1
Lawrence Corey
Independent Director2.3yrsUS$132.50k0%
$ 0
Timothy Chan
Member of Scientific Advisory Board7.4yrsNessun datoNessun dato
Eugene Zhukovsky
Member of Scientific Advisory Board5.6yrsNessun dato0%
$ 0
Graham Lord
Member of Scientific Advisory Board7.4yrsNessun datoNessun dato
Naiyer Rizvi
Independent Director & Member of Scientific Advisory Board8.4yrsUS$140.00k0%
$ 0
James Gulley
Member of Scientific Advisory Board7.4yrsNessun datoNessun dato
Alessandro Sette
Member of Scientific Advisory Board7.4yrsNessun datoNessun dato
Shefali Agarwal
Independent Director3.4yrsUS$138.50k0%
$ 0
Clare Fisher
Independent Director2.8yrsUS$136.50kNessun dato

6.5yrs

Durata media

61.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di GRTS.Q sono considerati esperti (durata media dell'incarico 6.5 anni).